| 10620184 |
SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein |
David B. Krizman, Todd Hembrough |
2020-04-14 |
| 10208130 |
Quantifying Her2 protein for optimal cancer therapy |
Yung-Jue Bang, Todd Hembrough, Do-Youn Oh |
2019-02-19 |
| 10126307 |
SRM/MRM assay for the androgen receptor (AR) protein |
David B. Krizman, Todd Hembrough, Sheeno Thyparambil |
2018-11-13 |
| 10078084 |
SRM/MRM assay for the mesothelin (MSLN) protein |
David B. Krizman, Todd Hembrough, Sheeno Thyparambil |
2018-09-18 |
| 10073075 |
SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein |
David B. Krizman, Todd Hembrough |
2018-09-11 |
| 10060927 |
SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein |
David B. Krizman, Todd Hembrough, Sheeno Thyparambil, Wei-Li Lao |
2018-08-28 |
| 9746477 |
Quantifying FR-α and GART proteins for optimal cancer therapy |
Todd Hembrough, Fabiola CECCHI, Manish MONGA |
2017-08-29 |